TAKEDA

By June 19, 2019 Closed

A Multicenter, Randomized, Double-Blind,  Placebo-Controlled Study to Determine the Efficacy and Safety of Alogliptin Plus Metformin, Alogliptin Alone, or Metformin Alone in Subjects with Type 2 Diabetes

Leave a Reply